CHIEF 在多种癌症类型中都达到了高准确率。在检测一种名为弥漫性大 B 细胞淋巴瘤的血液癌症中的 EZH2 基因突变时，CHIEF 达到了 96% 的准确率；在检测甲状腺癌中的 BRAF 基因突变时，CHIEF 的准确率达到了 ...

Artificial intelligence (AI)-based risk classification improves prognostication with localized prostate cancer, according to ...

Chennai: The State Consumer Disputes Redressal Commission (SCDRC) recently directed a consultant surgeon at a Erode-based ...

OCT for early diagnosis and characterization of dermatologic adverse events to oncologic drugs and correlation to ...

In May, it was confirmed Alder Hey would have to push back yet another deadline to hand back the entirety of Springfield Park ...

6 It was created by a deep learning multimodal artificial intelligence (MMAI) model from scanned digital histopathology slides and clinical parameters gathered from patients enrolled in five phase III ...

On a mission to collect a key Crohn’s disease approval and build out its inflammatory bowel disease (IBD) profile, Eli Lilly has notched a trial win over a major rival in a head-to-head study.